NCT03735186

Brief Summary

The present study will investigate the effect of acute exercise on fasting and postprandial risk markers for coronary heart disease (CHD) in healthy male cigarette smokers and non-smokers. Participants will complete two, 2-day trials in a random crossover design separated by an interval of at least 1 week. On day 1, participants will rest (control) or complete 60 minute of treadmill exercise at 60% of maximum oxygen uptake (exercise). On day 2, participants will rest and consume two high fat meals (breakfast and lunch) over an 8-h period during which 13 venous blood samples and nine blood pressure measurements will be taken at pre-determined intervals. It is hypothesised that men who smoke cigarettes will exhibit impaired fasting and postprandial metabolic risk markers compared to non-smokers, but a single bout of exercise will be equally, if not more, efficacious for improving the CHD risk factor profile in smokers than non-smokers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 4, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 2, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2018

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

October 30, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 8, 2018

Completed
Last Updated

November 9, 2018

Status Verified

November 1, 2018

Enrollment Period

1.2 years

First QC Date

October 30, 2018

Last Update Submit

November 7, 2018

Conditions

Keywords

Coronary heart diseaseExerciseInflammationPostprandial lipaemiaSmoking

Outcome Measures

Primary Outcomes (1)

  • Triacylglycerol concentration

    Total area under the plasma triacylglycerol concentration versus time curve on day 2

    8 hours (Plasma samples will be collected at 0 (fasted), 0.25, 0.5, 1, 2, 3, 4, 4.25, 4.5, 5, 6, 7, 8 hours)

Secondary Outcomes (14)

  • Glucose concentration

    8 hours (Plasma samples will be collected at 0 (fasted), 0.25, 0.5, 1, 2, 3, 4, 4.25, 4.5, 5, 6, 7, 8 hours)

  • Insulin concentration

    8 hours (Plasma samples will be collected at 0 (fasted), 0.5, 1, 3, 4, 4.5, 6, 8 hours)

  • Homeostasis model assessment of insulin resistance (HOMA-IR)

    Fasting (Plasma samples will be collected at 0 (fasted) hours)

  • Non-esterified fatty acids concentration

    8 hours (Plasma samples will be collected at 0 (fasted), 0.5, 1, 3, 4, 4.5, 6, 8 hours)

  • Total cholesterol concentration

    Fasting (Plasma samples will be collected at 0 (fasted) hours)

  • +9 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

Participants will rest in the laboratory on day 1 and day 2 (08:00-17:00). A high fat breakfast and lunch will be consumed on both days at pre-determined intervals.

Exercise

EXPERIMENTAL

Participants will complete 60 min of treadmill exercise on day 1 (14:30-15:30). Participants will rest in the laboratory for the remainder of day 1 and throughout day 2 (08:00-17:00). A high fat breakfast and lunch will be consumed on both days at pre-determined intervals.

Behavioral: Exercise

Interventions

ExerciseBEHAVIORAL

60 min treadmill exercise performed at 60% of maximum oxygen uptake.

Exercise

Eligibility Criteria

Age20 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • to 45-year-old healthy male smokers or non-smokers;
  • Be able to exercise continuously for 1 hour;
  • Body mass index between 18.5 and 29.9 kg/m2;
  • Weight stable for the past 3 months;
  • No known contradictions to maximal exertion exercise (e.g., recent musculoskeletal injury, congenital heart disease).
  • A regular cigarette smoker or non-smoker for the last 12 months according to the definition below;
  • The National Health Interview Survey (NHIS) definitions will be used to identify cigarette smokers and non-smokers (Link: NHIS Adult Tobacco Use):
  • Current smokers will be defined as an adult who has smoked ≥100 cigarettes in their lifetime and who currently smokes cigarettes every day.
  • Non-smokers will be defined as an adult who has never smoked or who has smoked \< 100 cigarettes in their lifetime
  • The following questions will determine the eligibility and group allocation:
  • Do you currently smoke cigarettes on a daily basis?
  • Have you smoked at least 100 cigarettes in your entire life?
  • If the person answers YES to Q1 and YES to Q2 they are eligible for the study and will be allocated to the smokers group.
  • If the person answers NO to Q1 and NO to Q2 they are eligible for the study and will be allocated to the non-smokers group.
  • Individuals answering any other combination (YES, NO or NO, YES) will not be eligible to take part in the study.

You may not qualify if:

  • Not meeting the criteria for a smoker or non-smoker (defined above);
  • Current E-Cigarette smoker;
  • Musculoskeletal injury that has affected normal ambulation within the last month;
  • Any muscle or bone injuries that do not allow them to walk and run on a treadmill;
  • Uncontrolled exercise-induced asthma;
  • Heart conditions;
  • Coagulation or bleeding disorders;
  • Diabetes (metabolism will be different to non-diabetics potentially skewing the data);
  • Taking any medication that might influence fat metabolism;
  • Taking any medication that might influence blood glucose (e.g., insulin for diabetes);
  • Dieting or restrained eating behaviours;
  • Weight fluctuation greater than 3 kg in the 3 months prior to study enrolment;
  • A food allergy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Loughborough University

Loughborough, Leicestershire, LE11 3TU, United Kingdom

Location

Related Publications (4)

  • Arjunan SP, Deighton K, Bishop NC, King J, Reischak-Oliveira A, Rogan A, Sedgwick M, Thackray AE, Webb D, Stensel DJ. The effect of prior walking on coronary heart disease risk markers in South Asian and European men. Eur J Appl Physiol. 2015 Dec;115(12):2641-51. doi: 10.1007/s00421-015-3269-7. Epub 2015 Oct 5.

    PMID: 26438068BACKGROUND
  • Arjunan SP, Bishop NC, Reischak-Oliveira A, Stensel DJ. Exercise and coronary heart disease risk markers in South Asian and European men. Med Sci Sports Exerc. 2013 Jul;45(7):1261-8. doi: 10.1249/MSS.0b013e3182853ecf.

    PMID: 23470315BACKGROUND
  • Miyashita M, Burns SF, Stensel DJ. Accumulating short bouts of brisk walking reduces postprandial plasma triacylglycerol concentrations and resting blood pressure in healthy young men. Am J Clin Nutr. 2008 Nov;88(5):1225-31. doi: 10.3945/ajcn.2008.26493.

    PMID: 18996856BACKGROUND
  • Alotaibi TF, Thackray AE, Roberts MJ, Alanazi TM, Bishop NC, Wadley AJ, King JA, O'Donnell E, Steiner MC, Singh SJ, Stensel DJ. Acute Running and Coronary Heart Disease Risk Markers in Male Cigarette Smokers and Nonsmokers: A Randomized Crossover Trial. Med Sci Sports Exerc. 2021 May 1;53(5):1021-1032. doi: 10.1249/MSS.0000000000002560.

MeSH Terms

Conditions

Cigarette SmokingCoronary DiseaseInsulin ResistanceInflammationMotor ActivitySmoking

Interventions

Exercise

Condition Hierarchy (Ancestors)

Tobacco SmokingBehaviorTobacco UseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • David Stensel

    Loughborough University

    PRINCIPAL INVESTIGATOR
  • Tareq Alotaibi

    Loughborough University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 30, 2018

First Posted

November 8, 2018

Study Start

August 4, 2017

Primary Completion

October 2, 2018

Study Completion

October 2, 2018

Last Updated

November 9, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share

Locations